Andrew S. Verderame
Senior Advisor
management
PharmaLex GmbH
Germany
Biography
Mr. Andrew S. Verderame, MBA, RAC has been Senior Advisor at Pharmalex Gmbh since joined in January 2015. Mr. Verderame provides consulting services for clients seeking drug development and product life cycle maintenance activities in the U.S. He has wealth of experience in leading over one hundred meetings with FDA, managing multi-site regulatory teams for both large and small pharmaceutical companies, and presenting to FDA Advisory Committees, with successful outcomes. He held senior regulatory affairs positions at EMD Serono, Replidyne, and Bayer HealthCare.
Research Interest
business
